For tens of thousands of patients, precision medicine is rewriting their cancer stories. But only a fraction of patients benefit. Can medicine close the gap?
From my cover story in the July 26, 2019, Newsweek
Linda Boyed, an energetic 52-year-old occupational therapist, was thrilled to be on vacation with her family in Hawaii, hitting the beaches and taking long walks. But she couldn’t shake a constant feeling of fatigue. When she returned home, her doctor delivered the bad news: Cancer of the bile ducts in her liver had already spread too far for chemotherapy or surgery to do any good. He offered to help keep her comfortable for her final few months.
But then Boyed’s husband found a doctor at Ohio State’s cancer center who was running studies of experimental drugs for gastrointestinal cancers. That doctor gave her an experimental drug called BGJ398. Boyed’s symptoms cleared up, the tumors stopped growing, and she regained the weight she had lost….Read more